| payload |
{"created_at":"2026-04-15T16:04:30.447 {"created_at":"2026-04-15T16:04:30.447546+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/tempus-ai-shares-climb-9-over-genopredicta-commercial-expansion-launch","value":{"fp":"336935c2a0d3a57e","kind":"unusual_volume","published_at":"2026-04-15T14:59:12+00:00","source":"Nasdaq Markets","summary":"(RTTNews) - Stock of Tempus AI, Inc. (TEM) is climbing about 9 percent on Wednesday morning trading after the company, along with Predicta Biosciences, announced the commercial expansion of a co-branded whole-genome sequencing assay, currently known as GenoPredicta.","tickers":["TEM"],"title":"Tempus AI Shares Climb 9% Over GenoPredicta Commercial Expansion Launch","url":"https://www.nasdaq.com/articles/tempus-ai-shares-climb-9-over-genopredicta-commercial-expansion-launch"}}... |